Advance in the medical treatment of multiple myeloma
- VernacularTitle:多发性骨髓瘤药物治疗的新进展
- Author:
Aijun LIU
;
Wenming CHEN
;
Lihong LI
- Publication Type:Journal Article
- Keywords:
multiple myeloma;
thalidomide;
proteasome inhibitors;
arsenic agents
- From:China Oncology
2006;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma is one of the common hematological malignant disease,but the treatment response was not very promising with conventional and high-dose chemotherapy.There are many new medicines or new therapies having been developed in recent years,such as thalidomide and its derivant,proteasome inhibitors,arsenic trioxide etc,they are more effective than conventional chemotherapy,such as oral melphalan and prednisone(MP);vincristine,doxorubicin,and dexamethasone(VAD).This paper summarize the recent advances in the new options for the treatment of multiple myeloma
